-
1
المؤلفون: Joanne Penko, Pengxiao C. Wei, David Sanchez-Migallon Guzman, Pamela G. Coxson, Dhruv S. Kazi, Kirsten Bibbins-Domingo
المصدر: Annals of Internal Medicine. 170:221
مصطلحات موضوعية: Male, Cost effectiveness, Cost-Benefit Analysis, Myocardial Infarction, Coronary Disease, 01 natural sciences, Brain Ischemia, law.invention, 0302 clinical medicine, Randomized controlled trial, law, Cause of Death, Medicine, 030212 general & internal medicine, Myocardial infarction, health care economics and organizations, Anticholesteremic Agents, General Medicine, Middle Aged, Stroke, Treatment Outcome, Cardiovascular Diseases, Drug Therapy, Combination, Female, Quality-Adjusted Life Years, medicine.drug, Adult, medicine.medical_specialty, Acute coronary syndrome, Statin, medicine.drug_class, Hypercholesterolemia, Antibodies, Monoclonal, Humanized, Decision Support Techniques, 03 medical and health sciences, Ezetimibe, Internal Medicine, Humans, Computer Simulation, Angina, Unstable, Acute Coronary Syndrome, 0101 mathematics, Aged, Alirocumab, business.industry, 010102 general mathematics, medicine.disease, Quality-adjusted life year, Emergency medicine, Hydroxymethylglutaryl-CoA Reductase Inhibitors, business, Follow-Up Studies
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1de8080629c4dfda8bd694298a29df5a
https://doi.org/10.7326/m18-1776